Artiva Biotherapeutics, Inc.
ARTV • XNAS
Artiva Biotherapeutics, Inc. is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Fred Aslan, with a market cap of $123.8M.
CEOFred Aslan
Next Earnings
Upcoming earnings announcement for Artiva Biotherapeutics, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (3:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.86
Earnings History
Past 7 earnings reports for Artiva Biotherapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.84Est: -$0.83 | -1.2% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.88Est: -$0.85 | -3.5% | - | — | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.87Est: -$0.80 | -8.7% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.83Est: -$0.66 | -25.8% | - | — | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.66Est: -$0.62 | -6.5% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.92Est: -$0.91 | -1.1% | -Est: $70.0K | -100.0% | 10-Q |
| Aug 29, 2024 | Q2 2024 | -$22.00Est: -$4.40 | -400.0% | -Est: $70.0K | -100.0% | 10-Q |